Prevention of tunneled cuffed hemodialysis catheter-related dysfunction and bacteremia by a neutral-valve closed-system connector: A single-center randomized controlled trial

American Journal of Kidney Diseases

Volumn 61, Issue 3, 2013, Pages 459-465

  Bonkain, Florence ^a   Racapé, Judith ^a   Goncalvez, Isabelle ^a   Moerman, Micheline ^a   Denis, Olivier ^a   Gammar, Nadia ^a   Gastaldello, Karine ^a   Nortier, Joëlle L ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

bacteremia; Tego connector; thrombosis; Tunneled cuffed hemodialysis catheter

Indexed keywords

CITRATE TRISODIUM; UROKINASE;

ADULT; AGED; ARTICLE; BACTEREMIA; CATHETER; CATHETER COMPLICATION; CATHETER RELATED DYSFUNCTION; CATHETER VALVE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE; NEUTRAL VALVE CLOSED SYSTEM CONNECTOR; RANDOMIZED CONTROLLED TRIAL; TUNNELED CUFFED CATHETER;

AGED; BACTEREMIA; CATHETER-RELATED INFECTIONS; CATHETERS, INDWELLING; EQUIPMENT DESIGN; EQUIPMENT FAILURE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS;

EID: 84874113262     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2012.10.014     Document Type: Article

References (20)

1. B.R. Di Iorio, V. Bellizzi, N. Cillo Vascular access for hemodialysis: the impact on morbidity and mortality J Nephrol 17 1 2004 19 25
2. R.L. Pisoni, C.J. Arrington, J.M. Albert Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis Am J Kidney Dis 53 3 2009 475 491
3. National Kidney Foundation. Vascular Access Work Group Clinical Practice Guidelines for Vascular Access Am J Kidney Dis 48(7) suppl 1 2006 S176 S247
4. J. Ethier, D.C. Mendelssohn, S.J. Elder Vascular access use and outcomes: an international perspective from the Dialysis Outcomes and Practice Patterns Study Nephrol Dial Transplant 23 10 2008 3219 3226
5. R.L. Pisoni, E.W. Young, D.M. Dykstra Vascular access use in Europe and the United States: results from the DOPPS Kidney Int 61 1 2002 305 316
6. M.C. Weijmer, Y.J. Debets-Ossenkopp, F.J. Van De Vondervoort, P.M. ter Wee Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients J Am Soc Nephrol 16 9 2005 2769 2777
7. B.R. Hemmelgarn, L.M. Moist, C.E. Lok Prevention of dialysis catheter lumen malfunction with recombinant tissue plasminogen activator N Engl J Med 364 4 2011 303 312
8. L. Labriola, R. Crott, M. Jadoul Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials Nephrol Dial Transplant 23 5 2008 1666 1672
9. D.L. Landry, G.L. Braden, S.L. Gobeille, S.D. Haessler, C.K. Vaidya, S.J. Sweet Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis Clin J Am Soc Nephrol 5 10 2010 1799 1804
10. M.C. Weijmer, Y.J. Debets-Ossenkopp, F.J. Van De Vondervoort, P.M. ter Wee Superior antimicrobial activity of trisodium citrate over heparin for catheter locking Nephrol Dial Transplant 17 12 2002 2189 2195
11. F. Bonkain, M. Wissing, J. Racapé, J. Nortier Thrombotic and infectious complications related to tunneled cuffed central venous catheters: a retrospective study in hemodialysis patients [abstract] Acta Clin Belg 64 2009 6
12. S. Eloot, J.Y. De Vos, R. Hombrouckx, P. Verdonck How much is catheter flow influenced by the use of closed luer lock access devices? Nephrol Dial Transplant 22 10 2007 3061 3064
13. J.W. Bosma, C.E. Siegert, P.G. Peerbooms, M.C. Weijmer Reduction of biofilm formation with trisodium citrate in haemodialysis catheters: a randomized controlled trial Nephrol Dial Transplant 25 4 2010 1213 1217
14. R.M. Shanks, J.L. Sargent, R.M. Martinez, M.L. Graber, G.A. O'Toole Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces Nephrol Dial Transplant 21 8 2006 2247 2255
15. I.M. Helander, T. Mattila-Sandholm Fluorometric assessment of gram-negative bacterial permeabilization J Appl Microbiol 88 2 2000 213 219
16. 2+ in E. coli Biochimie 81 8-9 1999 901 907
17. C.D. Punt, W.E. Boer Cardiac arrest following injection of concentrated trisodium citrate Clin Nephrol 69 4 2008 317 318
18. M.K. Willicombe, K. Vernon, A. Davenport Embolic complications from central venous hemodialysis catheters used with hypertonic citrate locking solution Am J Kidney Dis 55 2 2010 348 351
19. J.M. Macrae, I. Dojcinovic, O. Djurdjev Citrate 4% Versus Heparin and the Reduction of Thrombosis Study (CHARTS) Clin J Am Soc Nephrol 3 2 2008 369 374
20. A. Power, N. Duncan, S.K. Singh Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial Am J Kidney Dis 53 6 2009 1034 1041